schneider said that he is "not aware of any relevant risk of the drug" and that his team has "not observed side effects in thousands of treated animals."..
..
suven life sciences' pashamylaram facility successfully completes usfda inspection
.
.
money management is the professional's independent adviser, containing a wealth of in-depth features and unique fund performance statistics..
former novartis exec to lead cambridge diabetes startup semma.